NASA Armstrong Flight Research Center advanced multi-mission flight research in 2025, including supersonic testing, ...

Recent years have seen a growing movement away from animal testing and toward models that more closely replicate human physiology. This shift aims to protect animal welfare while concurrently ...

Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...

Washington, DC—Last month, both the National Institutes of Health and the US Food and Drug Administration announced plans to phase out the use of animals in scientific research. The Animal Welfare ...

Indian Railways is set to commission its first dedicated high-speed train testing facility by the end of the 2025–26 ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active role in supporting organizations in switching to an NAMs-based approach.

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...